Brill Pharma, a renowned pharmaceutical company in Spain that specializes in ophthalmic products, has extended its partnership with Girona FC for another three seasons. This agreement not only highlights Girona FC’s sporting success but also provides a valuable platform for the promotion of HYLO® and Brill Pharma on an international scale.
The renewal of this agreement reinforces Girona FC’s dedication to excellence and collaboration with industry-leading brands. HYLO®, known for its effectiveness in eye care, has become a trusted name in dry eye treatment in Spain, and this partnership with Girona FC will further enhance its presence in the sports sector. The ongoing collaboration between both parties demonstrates a shared commitment to excellence and innovation.
Brill Pharma is focused on providing innovative and effective eye care solutions, making it the exclusive distributor of the HYLO® range in Spain. HYLO® is a top brand in dry eye treatment, offering high-quality products that provide relief and protection for dry eyes. Owned by the prestigious Ursapharm Group in Germany, HYLO® has become a market leader due to its proven efficacy and safety.
This strategic partnership will bring significant benefits to both the Club and the HYLO® and Brill Pharma brands as they increase their visibility in the world of football and among the passionate fans of Girona FC. The renewal of this agreement highlights Girona FC’s commitment to excellence and collaboration with industry-leading brands while also promoting Brill Pharma’s innovative ophthalmic solutions through one of Spain’s most successful clubs.